BACKGROUND: Despite its widespread use, limited data on the validity of the Canadian Cardiovascular Society angina (CCSA) classification relative to other measures of functional status have been reported. OBJECTIVE: To assess the validity of the CCSA classification by comparing it with the Duke Activity Status Index (DASI) and evaluate its prognostic significance with respect to long-term mortality. METHODS: The study population consisted of 1407 patients who underwent cardiac catheterization between 1992 and 1996. The median follow-up period was 9.7 years (interquartile range 6.1 to 11.1 years) and the mortality status as of December 31, 2004 was available for all patients. RESULTS: The first three CCSA classes were inversely related to the DASI. The mean (+/- SD) scores were as follows: class I, 31.4+/-16.7; class II, 22.5+/-15.4; class III, 14.7+/-14.3; and class IV, 15.5+/-14.9 (P<0.01). Increasing CCSA class was associated with increased long-term mortality, even after adjusting for baseline characteristics. Chest pain course was also an important modulator of mortality among class III and IV patients; one-year mortality rates were 8.1% among unstable patients compared with 4.8% among patients with stable or progressing course. CONCLUSION: CCSA classes I to III were inversely related to DASI scores and linearly associated with mortality. The similarity in outcomes among class III and IV patients is probably explained by the confounding effect of the stability of the patients' symptoms. The higher mortality risk among class III and IV patients with an unstable course provides impetus for a revised CCSA definition incorporating this information.
BACKGROUND: Despite its widespread use, limited data on the validity of the Canadian Cardiovascular Society angina (CCSA) classification relative to other measures of functional status have been reported. OBJECTIVE: To assess the validity of the CCSA classification by comparing it with the Duke Activity Status Index (DASI) and evaluate its prognostic significance with respect to long-term mortality. METHODS: The study population consisted of 1407 patients who underwent cardiac catheterization between 1992 and 1996. The median follow-up period was 9.7 years (interquartile range 6.1 to 11.1 years) and the mortality status as of December 31, 2004 was available for all patients. RESULTS: The first three CCSA classes were inversely related to the DASI. The mean (+/- SD) scores were as follows: class I, 31.4+/-16.7; class II, 22.5+/-15.4; class III, 14.7+/-14.3; and class IV, 15.5+/-14.9 (P<0.01). Increasing CCSA class was associated with increased long-term mortality, even after adjusting for baseline characteristics. Chest pain course was also an important modulator of mortality among class III and IV patients; one-year mortality rates were 8.1% among unstable patients compared with 4.8% among patients with stable or progressing course. CONCLUSION: CCSA classes I to III were inversely related to DASI scores and linearly associated with mortality. The similarity in outcomes among class III and IV patients is probably explained by the confounding effect of the stability of the patients' symptoms. The higher mortality risk among class III and IV patients with an unstable course provides impetus for a revised CCSA definition incorporating this information.
Authors: H B Bosworth; I C Siegler; B H Brummett; J C Barefoot; R B Williams; N E Clapp-Channing; D B Mark Journal: Med Care Date: 1999-12 Impact factor: 2.983
Authors: M A Hlatky; R E Boineau; M B Higginbotham; K L Lee; D B Mark; R M Califf; F R Cobb; D B Pryor Journal: Am J Cardiol Date: 1989-09-15 Impact factor: 2.778
Authors: Jonathan Myers; Manish Prakash; Victor Froelicher; Dat Do; Sara Partington; J Edwin Atwood Journal: N Engl J Med Date: 2002-03-14 Impact factor: 91.245
Authors: Harry Hemingway; Natalie K Fitzpatrick; Shamini Gnani; Gene Feder; Neil Walker; Angela M Crook; Patrick Magee; Adam Timmis Journal: Can J Cardiol Date: 2004-03-01 Impact factor: 5.223
Authors: Gilles R Dagenais; Jiang Lu; David P Faxon; Peter Bogaty; Dale Adler; Francisco Fuentes; Jorge Escobedo; Ashok Krishnaswami; James Slater; Robert L Frye Journal: J Am Coll Cardiol Date: 2013-02-19 Impact factor: 24.094
Authors: Lynn M Baniak; Eileen R Chasens; Faith S Luyster; Patrick J Strollo; Erik Thunström; Yüksel Peker Journal: Sleep Breath Date: 2018-10-15 Impact factor: 2.816
Authors: Tiago José Nardi Gomes; Isabella Martins de Albuquerque; Patrícia de Moraes Costa; Dannuey Machado Cardoso; Gabriela de Moraes Costa; José Luiz da Costa Vieira Journal: Int J Gen Med Date: 2015-01-23
Authors: Michael Froehner; Anna-Elisa Kellner; Rainer Koch; Gustavo B Baretton; Oliver W Hakenberg; Manfred P Wirth Journal: BMC Urol Date: 2014-03-29 Impact factor: 2.264
Authors: Carmine Riccio; Michele Massimo Gulizia; Furio Colivicchi; Andrea Di Lenarda; Giuseppe Musumeci; Pompilio Massimo Faggiano; Maurizio Giuseppe Abrignani; Roberta Rossini; Francesco Fattirolli; Serafina Valente; Gian Francesco Mureddu; Pier Luigi Temporelli; Zoran Olivari; Antonio Francesco Amico; Giancarlo Casolo; Claudio Fresco; Alberto Menozzi; Federico Nardi Journal: Eur Heart J Suppl Date: 2017-05-02 Impact factor: 1.803
Authors: Janaine Cunha Polese; Thaianne C Servio; Gabriela Ss Chaves; Raquel R Britto; Luci F Teixeira-Salmela Journal: J Phys Ther Sci Date: 2016-04-28